Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,123 | 5,596 | 8,478 | 6,147 | 6,676 |
| Marketable Securities | 3,082 | 3,917 | 2,225 | 8,195 | 12,777 |
| Receivables | N/A | 1,101 | 1,274 | N/A | 439 |
| TOTAL | $11,926 | $10,614 | $11,977 | $16,040 | $19,892 |
| Non-Current Assets | |||||
| PPE Net | 188 | 217 | 237 | 250 | 262 |
| Other Non-Current Assets | 254 | 298 | 605 | 674 | 743 |
| TOTAL | $442 | $515 | $842 | $924 | $1,005 |
| Total Assets | $12,368 | $11,129 | $12,819 | $16,964 | $20,897 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 194 | 378 | 490 | 666 | 386 |
| Accrued Expenses | 464 | 666 | 1,644 | 1,563 | 3,124 |
| Other current liabilities | 479 | 386 | N/A | 874 | 727 |
| TOTAL | $1,137 | $1,430 | $2,247 | $3,218 | $4,349 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 179 | 209 | 230 |
| TOTAL | $N/A | $N/A | $179 | $209 | $230 |
| Total Liabilities | $1,137 | $1,430 | $2,426 | $3,427 | $4,579 |
| Shareholders' Equity | |||||
| Retained earnings | -109,745 | -108,003 | -105,946 | -102,623 | -99,660 |
| TOTAL | $11,231 | $9,699 | $10,393 | $13,537 | $16,318 |
| Total Liabilities And Equity | $12,368 | $11,129 | $12,819 | $16,964 | $20,897 |